Bioptik Technology Incorporation (TPEX:4161)
Taiwan · Delayed Price · Currency is TWD 27.00
+1.20 (4.65%)
At close: Feb 11, 2026
TPEX:4161 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 829.18 | 865.34 | 828.5 | 767.75 | 737.89 | 485.6 | |
Revenue Growth (YoY) | -6.21% | 4.45% | 7.91% | 4.05% | 51.95% | -14.27% |
Cost of Revenue | 580.69 | 597.43 | 588.96 | 590.29 | 574.35 | 402.44 |
Gross Profit | 248.5 | 267.91 | 239.54 | 177.46 | 163.55 | 83.16 |
Selling, General & Admin | 102.52 | 102.56 | 77.83 | 79.9 | 79.17 | 76.78 |
Research & Development | 73.22 | 75.35 | 71.47 | 58.3 | 48.94 | 50.15 |
Operating Expenses | 174.86 | 178.07 | 149.59 | 137.99 | 127.82 | 125.39 |
Operating Income | 73.64 | 89.84 | 89.95 | 39.48 | 35.73 | -42.23 |
Interest Expense | -7.74 | -9.13 | -11 | -9.19 | -7.82 | -8.47 |
Interest & Investment Income | 15.58 | 8.99 | 10.7 | 4.01 | 1.36 | 4.14 |
Currency Exchange Gain (Loss) | 0.09 | 13.32 | 4.95 | 29.94 | -9.45 | -15.58 |
Other Non Operating Income (Expenses) | 3.58 | 3.57 | 3.14 | 4.62 | 5.52 | 9.52 |
EBT Excluding Unusual Items | 85.14 | 106.58 | 97.75 | 68.86 | 25.34 | -52.62 |
Gain (Loss) on Sale of Investments | 4.63 | 4.63 | 8.69 | -6.14 | -5.72 | -5.6 |
Gain (Loss) on Sale of Assets | 1.22 | -0.9 | 0.02 | 0.06 | 0 | 0.07 |
Asset Writedown | - | - | - | - | - | -5.65 |
Other Unusual Items | - | - | 0.02 | 0.03 | - | 0.1 |
Pretax Income | 91 | 110.32 | 106.47 | 62.81 | 19.62 | -63.69 |
Income Tax Expense | 18.57 | 17.98 | 21.89 | 15.78 | -0.94 | -1.48 |
Earnings From Continuing Operations | 72.43 | 92.34 | 84.58 | 47.03 | 20.56 | -62.21 |
Minority Interest in Earnings | 1.15 | 1.23 | 1.13 | 1.47 | 2.04 | 2.23 |
Net Income | 73.58 | 93.57 | 85.71 | 48.5 | 22.59 | -59.99 |
Net Income to Common | 73.58 | 93.57 | 85.71 | 48.5 | 22.59 | -59.99 |
Net Income Growth | -26.19% | 9.17% | 76.73% | 114.67% | - | - |
Shares Outstanding (Basic) | 58 | 58 | 58 | 57 | 57 | 57 |
Shares Outstanding (Diluted) | 59 | 59 | 58 | 58 | 57 | 57 |
Shares Change (YoY) | 0.09% | 1.18% | 0.77% | 0.33% | 0.15% | -0.01% |
EPS (Basic) | 1.28 | 1.62 | 1.49 | 0.85 | 0.39 | -1.05 |
EPS (Diluted) | 1.25 | 1.59 | 1.48 | 0.84 | 0.39 | -1.05 |
EPS Growth | -26.32% | 7.79% | 75.34% | 113.67% | - | - |
Free Cash Flow | 79.18 | 143.9 | 175.53 | 38.13 | -60.29 | -6.46 |
Free Cash Flow Per Share | 1.35 | 2.45 | 3.03 | 0.66 | -1.05 | -0.11 |
Dividend Per Share | 0.266 | 0.266 | 0.619 | - | 0.253 | 0.253 |
Dividend Growth | -57.12% | -57.12% | - | - | - | -50.01% |
Gross Margin | 29.97% | 30.96% | 28.91% | 23.11% | 22.16% | 17.13% |
Operating Margin | 8.88% | 10.38% | 10.86% | 5.14% | 4.84% | -8.70% |
Profit Margin | 8.87% | 10.81% | 10.35% | 6.32% | 3.06% | -12.35% |
Free Cash Flow Margin | 9.55% | 16.63% | 21.19% | 4.97% | -8.17% | -1.33% |
EBITDA | 101.24 | 120.11 | 119.73 | 67.73 | 67.29 | -9.44 |
EBITDA Margin | 12.21% | 13.88% | 14.45% | 8.82% | 9.12% | -1.94% |
D&A For EBITDA | 27.6 | 30.27 | 29.78 | 28.25 | 31.57 | 32.79 |
EBIT | 73.64 | 89.84 | 89.95 | 39.48 | 35.73 | -42.23 |
EBIT Margin | 8.88% | 10.38% | 10.86% | 5.14% | 4.84% | -8.70% |
Effective Tax Rate | 20.41% | 16.30% | 20.56% | 25.12% | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.